Skip to content

    Sumitomo Chemical India Limited

    SUMICHEMGood
    Chemicals·28 May 2024
    Management Summary

    Sumitomo Chemical India delivered a resilient Q4 performance, marked by significant margin expansion despite a challenging full year for the agrochemical sector. While FY24 was marred by high-cost inventory liquidation and global pricing headwinds (25-30% drops in generics), the company successfully optimized its cost structure and working capital. Management is now pivoting toward volume-led growth and capacity expansion at Bhavnagar and Dahej to drive future performance.

    Highlights

    7
    • Q4 Revenue at ₹674 crores, up 3% YoY and 24% QoQ, showing signs of recovery.

    • Q4 EBITDA surged 74% YoY to ₹140 crores with margins expanding 843 bps to 20.8%.

    • FY24 Revenue declined 19% YoY to ₹2,844 crores due to global pricing pressure and erratic weather.

    • Gross margins in Q4 hit 41.7%, up 1,042 bps YoY, driven by liquidation of high-cost inventory and lower procurement costs.

    • Cash and cash equivalents stood strong at ₹1,207 crores as of March 31, 2024.

    • Management targets 12-15% volume growth for FY25 to offset generic price declines of 25-30%.

    • New product launches (last 2-3 years) targeted to contribute 8-10% of total revenue in FY25.

    Concerns

    1
    • Global Generic Pricing Pressure

    Key financials

    Single quarter

    04 metrics
    1. 01Revenue₹674 Cr+3%YoY
    2. 02EBITDA Margin20.8%
    3. 03PAT₹110 Cr+52%YoY
    4. 04Gross Margin41.7%

    Segment breakdown

    Agrochemicals (FY24 Revenue Mix)
    41% Insecticides22% Herbicide10% PGR8% Fungicides
    Geographic Mix (FY24)
    80% Domestic Revenue20% Export Revenue
    List

    Guidance & targets

    4
    CategoryTargetPriority
    Volume
    Volume Growth
    12-15%
    Medium
    Capex
    New Project Capex Cycle
    ₹250-300 crores
    High
    Revenue
    New Product Contribution
    8-10%
    Medium
    Other
    Green Power Generation
    100%
    High

    Risks & concerns

    5
    RiskSeverity

    Global Generic Pricing Pressure

    Generic prices have dropped 25-30%, requiring significant volume growth to maintain revenue levels.Management acknowledged

    high

    Geopolitical Supply Chain Disruption

    Potential closure of the Taiwan route could disrupt China-linked supply chains and increase transport costs.Management acknowledged

    medium

    Delayed Export Recovery

    Global destocking and LatAm weather issues have delayed the ramp-up of new export-oriented capacities like Tarapur.Both acknowledged

    medium

    Areas of Evasion(2)

    • Specific market share numbers for OLED/LED chemicals of the parent company.
    • Exact breakup of sales to group companies vs outsiders.

    Q&A highlights

    3

    “the prices itself have dropped 25% or so... the only answer to your question is to ramp up the volumes.”

    Confirms that revenue growth will be volume-driven as generic prices remain depressed.

    asked by Swati Hiroo

    2 min read5 chapters

    Detailed Narrative

    01

    Inventory Liquidation Drives Margin Recovery

    Sumitomo successfully liquidated high-cost inventory by the end of August 2023, allowing them to benefit from lower raw material prices in H2 FY24. This strategic move resulted in a massive 1,042 bps YoY expansion in Q4 gross margins to 41.7%. Management believes these margin levels are sustainable in a normalized environment, as they have moved past the 'extraordinary negative event' of high-cost inventory overhang.

    02

    Volume-Led Growth Strategy for FY25

    With generic product prices declining by 25-30% across the industry, Sumitomo is pivoting to a volume-driven strategy. The company targets a 12-15% volume growth in FY25 to compensate for lower realizations. This growth is expected to be supported by a normal monsoon forecast and the ramp-up of recently launched proprietary products, which are targeted to contribute 8-10% of revenue.

    03

    Capex and Capacity Expansion Timelines

    The company is embarking on a new capex cycle of ₹250-300 crores. While the Bhavnagar plant is expected to reach 100% export capacity in FY25, the Tarapur plant's full ramp-up has been pushed to FY26 due to global demand softness. For the Dahej site, environmental clearance is expected by the end of 2024, with the facility likely becoming operational in approximately two years (FY27).

    04

    Strategic Diversification into IT Chemicals

    A significant highlight was the mention of potential entry into IT/Electronic chemicals, a core strength of the Japanese parent company. Sumitomo India has received a preliminary inquiry from SCC Japan regarding the Indian market landscape for these products. While in early discussion stages, this represents a major potential long-term growth lever beyond the traditional agrochemical business.

    05

    ESG and Operational Efficiency

    Sumitomo is aggressively pursuing ESG goals, aiming to become a 100% green power generation company by the end of FY25 through a ₹25 crore investment in captive renewable energy. This initiative is expected to save approximately 2 crore units of electricity annually, with a cost saving of at least ₹4 per unit (totaling ~₹8 crores in annual savings). Additionally, the company reduced its working capital cycle by 33 days YoY through disciplined collection and inventory management.

    This is an AI-generated summary of a publicly available earnings call transcript. It is for informational purposes only and does not constitute investment advice, a recommendation, or an endorsement. inve.money is not a SEBI-registered investment advisor. Please consult a qualified financial advisor before making any investment decisions.